Benitec Biopharma Inc. (BNTC): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-17, first reflected in a filing dated 2023-09-21. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-06-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

34.42M
As of 2026-06-30
+174.1%
3-year compound annual growth
2019-06-30: 856.8K2020-06-30: 1.11M2021-06-30: 8.17M2022-06-30: 480.7K2023-06-30: 1.67M2024-06-30: 10.09M2025-06-30: 26.25M2026-06-30: 34.42M34.42M
2019-06-30 Shares Outstanding (shares) 2026-06-30

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2026-06-3034.42M+31.1%2026-09-14, Balance as of period end
2025-06-3026.25M+160.3%2026-09-14, Balance as of period end
2024-06-3010.09M+503.4%2026-03-20, Balance as of period end
2023-06-301.67Mn/c2024-09-26, Balance as of period end
2022-06-30480.7Kn/c2023-09-21, Balance as of period end
2021-06-308.17M+637.3%2022-09-02, Balance as of period end
2020-06-301.11M+29.4%2021-09-20, Balance as of period end
2019-06-30856.8Kn/a2020-09-23, Balance as of period end